EPI-589   Click here for help

GtoPdb Ligand ID: 13272

Synonyms: EPI589
Compound class: Synthetic organic
Comment: EPI-589 is a free-radical scavenger that was proposed to reduce cellular oxidative stress and mitochondrial dysfunction. The reduced form of EPI-589 is a substrate of NAD(P)H quinone oxidoreductases. EPI-589 is blood-brain barrier permeable and orally bioavailable.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 97.46
Molecular weight 265.31
XLogP -1.16
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=C(C)C(=O)C(=C(C)C1=O)CC[C@](C)(C(=O)N)O
Isomeric SMILES CC1=C(C(=O)C(=C(C1=O)C)CC[C@](C)(C(=O)N)O)C
InChI InChI=1S/C14H19NO4/c1-7-8(2)12(17)10(9(3)11(7)16)5-6-14(4,19)13(15)18/h19H,5-6H2,1-4H3,(H2,15,18)/t14-/m1/s1
InChI Key BAANPNDZFYBQIB-CQSZACIVSA-N
References
1. Haji S, Fujita K, Oki R, Osaki Y, Miyamoto R, Morino H, Nagano S, Atsuta N, Kanazawa Y, Matsumoto Y et al.. (2023)
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.
JMIR Res Protoc, 12: e42032. [PMID:36716091]
2. Noda N, Hamatani T, Shibue Y, Takagaki T, Kitamura A, Haranaka M, Ogama Y, Kakuyama H. (2022)
Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI-589 in Healthy Participants.
Clin Pharmacol Drug Dev, 11 (10): 1136-1146. [PMID:35988057]